Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NATUR-DROGERIET HOLDING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.0% 1.0% 0.9% 1.0% 1.0% 0.9% 11.3% 11.3%   Credit score (0-100)   89 88 89 85 87 87 22 22   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   1,296.3 1,248.0 1,513.7 1,116.1 1,192.6 1,338.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   340 157 336 196 150 403 0.0 0.0   EBITDA   340 157 336 196 150 403 0.0 0.0   EBIT   97.2 -86.8 92.5 -47.4 -110 144 0.0 0.0   Pre-tax profit (PTP)   1,134.7 1,046.6 1,284.4 1,082.0 1,049.8 1,331.0 0.0 0.0   Net earnings   1,103.8 1,086.6 1,273.9 1,128.3 1,117.7 1,335.5 0.0 0.0   Pre-tax profit without non-rec. items   1,135 1,047 1,284 1,082 1,050 1,331 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   12,640 12,459 12,215 11,971 12,485 12,226 0.0 0.0   Shareholders equity total   21,872 21,459 21,233 20,799 19,416 19,752 730 730   Interest-bearing liabilities   8,207 9,171 8,332 9,724 7,877 6,053 0.0 0.0   Balance sheet total (assets)   32,700 33,041 31,651 32,435 29,613 28,777 730 730   Net Debt   7,971 9,051 8,007 9,702 7,124 5,310 -730 -730     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   340 157 336 196 150 403 0.0 0.0   Gross profit growth   40.7% -53.8% 114.1% -41.6% -23.9% 169.5% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   32,700 33,041 31,651 32,435 29,613 28,777 730 730   Balance sheet change%   0.9% 1.0% -4.2% 2.5% -8.7% -2.8% -97.5% 0.0%   Added value   339.7 157.1 336.3 196.4 134.1 402.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -2,071 -424 -488 -488 255 -519 -9,063 -3,262   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.6% -55.2% 27.5% -24.2% -73.4% 35.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.4% 4.2% 4.8% 4.4% 4.4% 5.4% 0.0% 0.0%   ROI %   4.6% 4.3% 5.0% 4.5% 4.6% 5.7% 0.0% 0.0%   ROE %   5.0% 5.0% 6.0% 5.4% 5.6% 6.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   66.9% 64.9% 67.1% 64.1% 65.6% 68.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,346.4% 5,763.2% 2,380.9% 4,940.9% 4,765.0% 1,318.1% 0.0% 0.0%   Gearing %   37.5% 42.7% 39.2% 46.8% 40.6% 30.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 3.7% 3.2% 3.6% 3.6% 3.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.4 0.9 1.0 0.7 0.6 2.2 0.0 0.0   Current Ratio   1.4 0.9 1.0 0.7 0.6 2.2 0.0 0.0   Cash and cash equivalent   236.0 119.8 324.8 21.7 752.7 742.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,064.8 -301.9 35.6 -1,267.6 -976.4 1,754.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0